Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Czock

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|January 7, 2005
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoidsDavid Czock, Frieder Keller, Franz Maximilian Rasche, et al.
Therapeutic Drug Monitoring|October 3, 2022
Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy VolunteersYoana Aurelia Djaelani, Thomas Giese, Claudia Sommerer, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Raloxifene pharmacokinetics in males with normal and impaired renal functionDavid Czock, Frieder Keller, Mette Heringa, et al.
Acta Oto-Laryngologica. Supplementum|March 17, 2005
Tonsillectomy, high dose immunoglobulins, and cyclophosphamide in progressive IgA-nephropathyFranz Maximilian Rasche, Leif-Conradin Sailer, David Czock, et al.
NDT Plus|May 19, 2015
Rituximab in two cases of Goodpasture's syndromeBirgit Schless, Suzan Yildirim, Daniel Beha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Review on pharmacokinetics and pharmacodynamics and the aging kidneyChristian Aymanns, Frieder Keller, Sebastian Maus, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Levomethadone is poorly removed by the molecular adsorbents recirculating systemDavid Czock, Frieder Keller, Jörn Hameister, et al.
The Annals of Pharmacotherapy|February 6, 2009
Irinotecan in cancer patients with end-stage renal failureDavid Czock, Franz Maximilian Rasche, Benjamin Boesler, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Pharmacokinetics of valganciclovir and ganciclovir in renal impairmentDavid Czock, Cornelia Scholle, Franz Maximilian Rasche, et al.
Cureus|July 18, 2022
Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease Treated With Autologous Stem Cell Transplantation Using a Modified TEAM RegimenKudret Kama, Paul La Rosée, David Czock, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|January 7, 2005
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoidsDavid Czock, Frieder Keller, Franz Maximilian Rasche, et al.
Therapeutic Drug Monitoring|October 3, 2022
Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy VolunteersYoana Aurelia Djaelani, Thomas Giese, Claudia Sommerer, et al.
British Journal of Clinical Pharmacology|April 2, 2005
Raloxifene pharmacokinetics in males with normal and impaired renal functionDavid Czock, Frieder Keller, Mette Heringa, et al.
Acta Oto-Laryngologica. Supplementum|March 17, 2005
Tonsillectomy, high dose immunoglobulins, and cyclophosphamide in progressive IgA-nephropathyFranz Maximilian Rasche, Leif-Conradin Sailer, David Czock, et al.
NDT Plus|May 19, 2015
Rituximab in two cases of Goodpasture's syndromeBirgit Schless, Suzan Yildirim, Daniel Beha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Review on pharmacokinetics and pharmacodynamics and the aging kidneyChristian Aymanns, Frieder Keller, Sebastian Maus, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Levomethadone is poorly removed by the molecular adsorbents recirculating systemDavid Czock, Frieder Keller, Jörn Hameister, et al.
The Annals of Pharmacotherapy|February 6, 2009
Irinotecan in cancer patients with end-stage renal failureDavid Czock, Franz Maximilian Rasche, Benjamin Boesler, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Pharmacokinetics of valganciclovir and ganciclovir in renal impairmentDavid Czock, Cornelia Scholle, Franz Maximilian Rasche, et al.
Cureus|July 18, 2022
Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease Treated With Autologous Stem Cell Transplantation Using a Modified TEAM RegimenKudret Kama, Paul La Rosée, David Czock, et al.
Pageof 11